KPC Pharmaceuticals issues new guarantees for subsidiaries' operations

KPC Pharmaceuticals Inc. has issued new external guarantees totaling 14 million yuan for its wholly-owned and controlled subsidiaries. The guarantees, approved by the board and shareholders, include 5 million yuan for Kunming Pharmaceutical Commercial Xishuangbanna Dai Medicine Management Co., Ltd. and 9 million yuan for Dali Huirui Pharmaceutical Co., Ltd. These guarantees aim to enhance financing efficiency and reduce costs for the subsidiaries.

As of the announcement date, the company's total external guarantee balance for its subsidiaries amounts to 456.15 million yuan, representing 8.68% of its latest audited net assets. The guarantees are part of the company's previously approved 2025 guarantee plan, which includes a total guarantee capacity of 456.15 million yuan for its subsidiaries.

The guarantees are considered low-risk, as KPC Pharmaceuticals has close oversight of its subsidiaries' operations, credit status, and financial performance. All guaranteed entities are current on their obligations, with no overdue guarantees reported.